Abstract: A hydrogenation catalyst, and preparation and use thereof are provided. The catalyst has a support and a hydrogenation active metal component, a phosphorus component and an organic complexing component supported on the support. The hydrogenation active metal component has a Group VIII metal and a Group VIB metal, the organic complexing component has an alcohol, a carboxylic acid, and/or an amine. The catalyst has a spectrum obtained by a temperature-programmed oxidation test exhibiting at least two CO2 release peaks, the first release peak being in the range of 200-300° C., the second release peak being in the range of 300-400° C. The ratio of the peak height of the first release peak to the peak height of the second release peak is in the range of 0.5-5:1.

Abstract: The present application relates to a hydrogenation catalyst, a process for producing the same and application thereof in the hydrotreatment of feedstock oil. The process comprises at least the following steps: (1) contacting a first active metal component and a first organic complexing agent with a carrier to obtain a composite carrier; (2) calcining the composite carrier to obtain a calcined composite carrier having a total carbon content of 1% by weight or less; and (3) contacting a second organic complexing agent with the calcined composite carrier to obtain the hydrogenation catalyst. The hydrogenation catalyst has both excellent hydrodesulfurization activity and hydrodenitrogenation activity, and exhibits a significantly prolonged service life.

Abstract: The present application relates to a hydrogenation catalyst, a process for producing the same and application thereof in the hydrotreatment of feedstock oil. The process comprises at least the following steps: (1) contacting a first active metal component and a first organic complexing agent with a carrier to obtain a composite carrier; (2) calcining the composite carrier to obtain a calcined composite carrier having a total carbon content of 1% by weight or less; and (3) contacting a second organic complexing agent with the calcined composite carrier to obtain the hydrogenation catalyst. The hydrogenation catalyst has both excellent hydrodesulfurization activity and hydrodenitrogenation activity, and exhibits a significantly prolonged service life.

Abstract: The present invention relates to the field of a pharmaceutical compound, and more specifically, relates to a new oxazolidone compound, an enantiomer, a diastereoisomer and a raceme thereof, and a mixture thereof, and a pharmaceutically acceptable salt thereof, a preparation method thereof, an application thereof as a bioactive substance in a drug. The compound in the present invention has strong anticoagulant activity, does not affect the activity of thrombin, and can reduce the risk of hemorrhage. A pharmacokinetics experiment shows that the compound in the present invention further has good metabolic characteristics, and has a far better oral bioavailability than a positive contrastive agent rivaroxaban.

Abstract: The present invention relates to the field of a pharmaceutical compound, and more specifically, relates to a new oxazolidone compound, an enantiomer, a diastereoisomer and a raceme thereof, and a mixture thereof, and a pharmaceutically acceptable salt thereof, a preparation method thereof, an application thereof as a bioactive substance in a drug. The compound in the present invention has strong anticoagulant activity, does not affect the activity of thrombin, and can reduce the risk of hemorrhage. A pharmacokinetics experiment shows that the compound in the present invention further has good metabolic characteristics, and has a far better oral bioavailability than a positive contrastive agent rivaroxaban.